Bibliographic record
Liraglutide and cardiovascular outcomes in type 2 diabetes
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JFE, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM…. New England Journal of Medicine 2016
§1Bibliographic record
§1.1Record
- Authors
- Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JFE, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB
- Title
- Liraglutide and cardiovascular outcomes in type 2 diabetes
- Source
- New England Journal of Medicine
- Year
- 2016
- Volume, issue, pages
- 375(4):311–322
- Digital object identifier
- 10.1056/NEJMoa1603827
- PubMed identifier
- 27295427
- Record type
- Journal article
- Institute identifier
- CEI-BR-073
§1.2Institute documents citing this record
Table 1. Documents in the Institute set that cite this record.
| Document | Series |
|---|---|
| Monograph: Liraglutide | Compound monograph |
| Trial abstract: LEADER | Trial abstract |
| Synthesis: Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists | Evidence synthesis |
| Synthesis: Liraglutide in obesity and overweight in adults: effect on the anchor… | Evidence synthesis |
| Synthesis: Liraglutide in adjunctive therapy in type 1 diabetes: effect on the… | Evidence synthesis |
| Synthesis: Liraglutide in type 2 diabetes mellitus: effect on the anchor outcome | Evidence synthesis |
| Synthesis: Liraglutide in obesity and overweight in adults: tolerability and… | Evidence synthesis |
| Synthesis: Liraglutide in adjunctive therapy in type 1 diabetes: tolerability… | Evidence synthesis |
| Synthesis: Liraglutide in type 2 diabetes mellitus: tolerability and… | Evidence synthesis |
| Synthesis: Liraglutide in obesity and overweight in adults: durability of effect | Evidence synthesis |
| 10 citing documents. | |
§1.3Subject tags
liraglutide cardiovascular LEADER
Compound Evidence Institute · CEI-BR-073 · https://compoundevidence.com/bibliography/marso2016b/ · retrieved 30 July 2026